An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on a forum asked how to switch from one investigational peptide called “Reta” (likely retatrutide) to another called “Triz” (likely tirzepatide). They’ve been using retatrutide for about five weeks at 2.5 mg and are thinking of dropping to 1 mg or 0.5 mg a week before switching. They say they started retatrutide to help with binge-eating, and they’re a fairly lean person — about 125–130 pounds at 5’6”. Retatrutide and tirzepatide are both drugs that act like natural hormones that help control appetite and blood sugar, but they are different molecules. Retatrutide is an experimental peptide that targets several gut-brain hormone receptors to reduce appetite and increase feelings of fullness. Tirzepatide is an approved diabetes drug (sold under names like Mounjaro) that also helps with weight by acting on two hormone systems: GLP-1 and GIP (both are gut hormones that affect hunger and insulin). In plain terms: both are “peptides” (short proteins) designed to trick your body into feeling less hungry, but they aren’t identical and can have different effects and side effects. What the science shows is limited and specific. Tirzepatide has clinical trials in large groups of people showing it lowers blood sugar and causes substantial weight loss in many patients, and it’s FDA-approved for diabetes and approved as a weight-loss drug under a different brand. Retatrutide is further behind in testing; early trials suggest it may be powerful for appetite and weight loss, but the data come from small, controlled studies and not from widespread real-world use. The forum post is a single person’s plan, not a clinical recommendation. There’s no clear published protocol that says how to taper one peptide and start another, and effects can differ based on dose, how long you’ve been on the drug, and your individual body. Why this matters to someone like the poster: switching between peptides can change how your appetite, blood sugar, and side effects behave. If you’ve been using these drugs to manage binge eating, the timing and dosing of a switch could affect cravings or trigger withdrawal-like symptoms (nausea, changes in bowel habits, or rebound appetite). Also, being fairly low body weight to begin with changes the risk-benefit balance—drugs that cause weight loss may not be appropriate if you’re already lean. Anyone considering a change should talk to a doctor who knows these medications, because they can advise on safe dosing and monitor for problems. Caveats and risks: you should not rely on forum advice for medication changes. These drugs can cause nausea, vomiting, diarrhea, low blood sugar (especially if you’re on diabetes meds), and in rare cases pancreatitis or gallbladder issues. Retatrutide is experimental and may not be approved or available outside trials; tirzepatide is prescription-only. Stopping or switching without medical supervision can lead to unwanted side effects or return of binge-eating symptoms. If you have eating-disorder concerns, involve both a prescriber and a therapist experienced with eating disorders. Bottom line: don’t self-manage a switch between these peptides based on internet tips—talk to a knowledgeable clinician who can help plan doses, monitor you, and support your eating-disorder care.
Source: r/Peptides